The Economic Times
English EditionEnglish Editionहिन्दी
| E-Paper
Search
+

When the pandemic hit, India's healthcare industry was quick to adapt to the need of the hour

When the pandemic hit, India's healthcare industry was quick to adapt to the need of the hour
When the pandemic hit, India's healthcare industry was quick to adapt to the need of the hour

Synopsis

Indian diagnostic companies had experience in developing test assays for dengue, HIV, TB and H1N1, but with Covid-19 the delay in getting hold of the genetic code of SARS-Cov2 meant the Indian government, in the initial months of the pandemic, had to wait on imported RT-PCR kits that were expensive with worldwide shortage. In March, the Indian Council of Medical Research placed an order of one million probes from Germany.

NEW DELHI | MUMBAI: As countries scrambled to find medical essentials for front-line workers and patients fighting the pandemic, India’s healthcare entrepreneurs and industry stepped in to fill the shortage. From diagnostic makers developing RT-PCR testing kits in record time to manufacturers of personal protection equipment (PPE) and N95 masks, companies revamped assembly lines to expedite manufacturing.Indian diagnostic companies had
Share This Article
  • GIFT ARTICLE
  • FONT SIZE
  • SAVE
  • COMMENT

Sign in to read the full article

You’ve got this Prime Story as a Free Gift

Why ?

  • Sharp Insight-rich, Indepth stories across 20+ sectors

  • Access the exclusive Economic Times stories, Editorial and Expert opinion

  • Clean experience with
    Minimal Ads
  • Comment & Engage with ET Prime community
  • Exclusive invites to Virtual Events with Industry Leaders
  • A trusted team of Journalists & Analysts who can best filter signal from noise
The Economic Times